SeaStar Medical Holding Corp (ICU): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
SeaStar Medical Holding Corp (ICU) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. icu20260630_8k.htm false 0001831868 0001831868 2026-06-25 2026-06-25 0001831868 icu:CommonStockCustomMember 2026-06-25 2026-06-25 0001831868 icu:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockFor1150PerShareCustomMember 2026-06-25 2026-06-25 UNITED STATES SECURITIES A
How this was made
The 30-second read
Why it matters
The disclosure provides concrete compensation terms (cash amounts, vesting/payment dates, and stock-based share settlement mechanics) for two executives, which can influence expectations around future dilution and retention stability.
Market read
Traders may monitor for small dilution/issuance expectations tied to the scheduled vesting dates, but there is no operational or financial guidance change.
What to watch
If the company’s share price is volatile, the share count delivered at each vesting date (based on closing price) could change the effective dilution more than the dollar bonus amounts suggest.
Background
The company filed an SEC Form 8-K (Item 5.02) describing retention bonuses approved by the Compensation Committee and formalized via retention bonus program agreements.
Ticker impact
SeaStar Medical Holding approved retention bonuses for executives Eric Schlorff and Kevin Chung, with vesting/pay dates through March 1, 2027.
Likely limited, with any impact concentrated around vesting/payment dates rather than immediately.
The filing discloses specific bonus amounts and vesting schedule, but it is not a financing, guidance change, or operational milestone; effects are typically incremental for microcaps.
Market effects
No direct sector read-across; this is company-specific compensation/retention disclosure.
None indicated; Nasdaq-listed filing with no macro/regional catalyst.
None indicated; no international transaction or regulatory action described.
Counterpoint
The stock-based component (25% of each payment in shares) could be viewed as supportive for retention and continuity, potentially reducing execution risk despite dilution.
Key entities
- companySeaStar Medical Holding Corporation
Nasdaq-listed registrant (ICU) disclosing executive retention bonuses and vesting/payment schedule via Form 8-K.
- executiveEric Schlorff
Executive receiving a $200,000 retention bonus split into three 1/3 payments with stock-based add-on.
- executiveKevin Chung
Executive receiving a $140,000 retention bonus split into three 1/3 payments with stock-based add-on.



